The Justification of a Ag- Health Research Strategy in Canada What is CCARM? Our Journey from Bench to Bedside to Better Living Grant N Pierce PhD, FACC,

Slides:



Advertisements
Similar presentations
Human Trials Gold standard: Controlled, double-blind; versus greater potential of whole food diet Vitamins/minerals/etc. for learning and behavior (Controlled,
Advertisements

Analysis of the ADVANCE Trial Sapna N. Patel UCSF Pharm. D. Candidate 2008 Preceptor Dr. Craig S. Stern March 28, 2008.
Good Fats 101: Nutrition Education for Supermarket Shoppers.
Group Wellness Program 60-DAY. The Best Medicine.
CHD Prevention and Risk Asssessment: Old concepts new context? Dr Paul D MacIntyre Director of Cardiology, RHH.
METHODS A systematic review of evidence-based literature was performed using Medline and Cochrane databases. Studies reviewed include randomized controlled.
Marge Koepping, MN, FNP, BC-ADM, CDE Warm Springs Model Diabetes Program Warm Springs SDPI Diabetes Prevention Program.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Zhai, Public Health Nutrition, Feb 2002 WHAT IS CHINA DOING IN POLICY-MAKING TO PUSH BACK THE NEGATIVE ASPECTS OF THE NUTRITION TRANSITION? Fengying Zhai.
Non Communicable Disease
Cardiovascular Disease: Predicting Risk and Monitoring Outcomes Monica R. Shah, MD, FACC NHLBI AIDS Coordinator Conference on Retroviruses and Opportunistic.
Pass The Fat! James R. Ginder, MS, NREMT,PI,CHES
Cholesterol. The Good the Bad the Ugly.
Hypertension (high blood pressure) Dr. Fiona Gillan GP Registrar at Church End Medical Centre.
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
Coronary Heart Disease (CHD): A Disease of Affluence.
Heart Disease Effects of lifestyle on coronary heart disease Sara Quale ∙ Concordia University-Nebraska 1.
SATURATED FAT TO EAT IT, OR NOT TO EAT IT? Rachel Peterson Macronutrients.
Healthy Living Factors in Preventing Serious Disease ( Diabetes, Cancer Heart Attack, Stroke)
A Healthy Heart What Women Need to Know By Jordan Robertson, ND.
MI: Risk Factors and Primary Prevention. Risk Factors Factors that appear to increase the general population’s chances of experiencing a health problem.
1. Public Awareness Survey on 2,000 People with Diabetes (Fall 2001)  Findings: –68% do not consider cardiovascular disease to be complication of diabetes.
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
Do you know someone who has been a victim of a heart attack or stroke? VideoVideo - Watch your own heart attack.
Chapter 16 Circulation. Section 3 Cardiovascular Diseases – Diseases of the cardiovascular system include atherosclerosis and hypertension – Atherosclerosis.
WELCOME!!!. Fat Budgeting Mary Fisler, RN Fat Budgeting Agenda –High Cost of Fat in our Diets –Watch “Don’t Eat Your Heart Out”Video –Calculate Your.
More Palatable Nutrition Guidelines Ron Krauss, MD Senior Scientist, Head of Molecular Medicine Lawrence Berkeley National Laboratory University of California.
CARDIOVASCULAR DISEASE The Nature of CVD Extent and Trend of CVD Risk factors Social determinants High Risk Groups.
Incidence of saturated and unsaturated fats in the diet of a group of patients with cardiovascular disease Autor: Sărmăşan Anişoara Alina Prof. Coordonator:
Fats. Functions of Fat Provides energy Adds flavor to food Helps satisfy the appetite Helps promote growth and healthy skin Protects vital organs Vitamins.
BY ONDINE AND SARAH Hyperlipidemia. What Is Hyperlipidemia? Hyperlipidemia is the presence of abnormal or raised levels of lipids (fats) or lipoproteins.
Agenda Introduction Model purpose Overall plan Schema Discussion Next Steps.
 2010 Wellsource, Inc. All rights reserved. Polyunsaturated Fats and CHD Harvard Study 2010.
Elizabeth Ofili, M.D., M.P.H., F.A.C.C. Professor of Medicine and Chief of Cardiology Director, Clinical Research Center Associate Dean of Clinical Research.
CARDIOVASCULAR DISEASES Heart Attack Definition- is the death of part of the heart muscle caused by lack of blood flow to the heart. A heart attack can.
CARDIOVASCULAR DISEASE. 2 parts Heart (Cardio) Blood Vessels (Vascular)
Nutrition & Physical Activity. WARM UP  Everyone stand at your desk  If you have an index card you need to think of 1 or 2 ways you can reduce your.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
ASSOCIATION OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL WITH INCIDENT CARDIOVASCULAR EVENTS IN WOMEN, BY LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN.
2009 Fire/EMS Safety, Health and Survival Week Firefighter Health.
N-3fatty acids in cardiovascular disease DR.AMINI.
Finding the Evidence Approximately 8,000 completed references are added to MEDLINE each week (over 400,000 added per year) Too much for any one person.
Definition of the ‘health transition’ Trends of disease patterns in populations The 4 stages of the epidemiological transition The cardiovascular disease.
THE ASSOCIATIONS AMONG SOCIAL CAPITAL, HEALTH BEHAVIOURS, AND COGNITIVE MECHANISMS IN CARDIAC OUTPATIENTS Valerie Haboucha 1,2, Darren A Mercer 1,2,3,
Can lifestyle moderate the burden of CVD? Evangelos Polychronopoulos, MD, MPH, PhD Asst Professor of Preventive Medicine Harokopio University.
Methodological Issues in Systematic Review - Formulating Questions - Joseph Lau, MD Tufts Medical Center EPC AHRQ Annual Meeting September 10, 2008.
The Effects of Brisk Walking on Biochemical Risk Factors and Functional Capacity in Healthy, Sedentary 50 to 65 Year Old Patients of Primary Care M.Tully.
The Health Benefits of Olive Oil By Mona Douglas.
Long-Term Tolerability of Ticagrelor for Secondary Prevention: Insights from PEGASUS-TIMI 54 Trial Marc P. Bonaca, MD, MPH on behalf of the PEGASUS-TIMI.
Long-Term Tolerability of Ticagrelor for Secondary Prevention: Insights from PEGASUS-TIMI 54 Trial Marc P. Bonaca, MD, MPH on behalf of the PEGASUS-TIMI.
Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC Yazid NJ Al Hamarneh, BPharm, PhD Charlotte Jones, MD, PhD, FRCP(C) Brenda Hemmelgarn, MD, PhD, FRCP(C)
Food and cardiovascular heart disease Pedro Marques-Vidal IUMSP Lausanne, Switzerland.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
PUTTING PREVENTION FIRST Vascular Checks Dr Bill Kirkup Associate NHS Medical Director.
NHS Health Check programme An opportunity to engage 15 million people to live well for longer Louise Cleaver National Programme Support Manager.
Lesson 4 1 The Healthy Eating Manual, Nutrition Resource Centre, 2011 Healthy Eating with Fats on the Menu Lesson
Fast fOod Shops Significantly Impact Cardiovascular Karma - the FOSSICK IV Trial - Reddy M, Luque M, Ferrer Ferrer L, Koju R, Zaman MJ, Inspiron D, Caprnda.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
+ Take Charge of Your Health Health for Hearts United Leadership Institute Cyneetha Strong, MD May 31, 2014.
Nordic School of Public Health Nordic Centre for research and studies in Public Health Nordic School of Public Health (NHV) was established by the five.
Cardiovascular Disease and Antihypertensives The RENAAL Trial Reference Brunner BM, and the RENAAL study group. Effects of losartan on renal and cardiovascular.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Heart Disease in Indians
Note World Health Organisation indicated on 5 March
Preventing Cardiovascular Disease
Andre Lamy on behalf of the COMPASS Investigators
CANTOS: The Canakinumab Anti-Inflammatory Thrombosis Outcomes Study
Risk factor thresholds: their existence under scrutiny
Hypertension Management at the VA Geriatric Clinic
The Hypertension in the Very Elderly Trial (HYVET)
Presentation transcript:

The Justification of a Ag- Health Research Strategy in Canada What is CCARM? Our Journey from Bench to Bedside to Better Living Grant N Pierce PhD, FACC, FAHA, FAPS, FISHR, FIACS, FCAHS Executive Director of Research, St. Boniface General Hospital, Assistant Dean of Research, Faculty of Medicine, University of Manitoba, Winnipeg

Why do we need research on the health/nutrition association? What research organizations may help? Are there examples?

Heart disease is by far the leading cause of death today and and it is the largest drain on our health care system

Over 90% of all heart disease can be predicted from 3 factors Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 Sep 11-17;364(9438): Yusuf S et al and the INTERHEART investigators

1.Stop smoking 2. Nutrition 3. Exercise All are modifiable

If this is true, then we have the capacity to alter the leading cause of death today by >90%

If we already have the knowledge on what can reduce the incidence of the primary cause of death and the largest cost to our health care sector (by 90%), Then we have healthy living in the palm of our hand. We only need the will to institute and support a plan of preventive medicine. If we already have the knowledge on what can reduce the incidence of the primary cause of death and the largest cost to our health care sector (by 90%), Then we have healthy living in the palm of our hand. We only need the will to institute and support a plan of preventive medicine.

Nutrition is one of the most important weapons in our preventive medicine arsenal. How is all of this relevant to the agriculture sector? Nutrition is one of the most important weapons in our preventive medicine arsenal. How is all of this relevant to the agriculture sector?

The demand for a crop is directly related to its health related benefits.

If demand increases, price will increase. If demand increases, consumption will increase. If demand, price and consumption increases, crop size & value will increase. Who benefits? The farmer and the entire ag industry will reap immediate benefits (farmgate to marketplace) If demand increases, price will increase. If demand increases, consumption will increase. If demand, price and consumption increases, crop size & value will increase. Who benefits? The farmer and the entire ag industry will reap immediate benefits (farmgate to marketplace)

Still don’t believe there is a direct relationship between health and the entire ag sector as a business? Ask egg farmers Better yet, ask coconut plantation owners in the Caribbean Ask canola farmers Still don’t believe there is a direct relationship between health and the entire ag sector as a business? Ask egg farmers Better yet, ask coconut plantation owners in the Caribbean Ask canola farmers

I’ve led you down a pathway of logic that AAFC understood and acted upon. It is applicable to every chronic disease. It has resulted in a unique research facility in Winnipeg: The Canadian Centre for Agri-food Research in Health and Medicine (CCARM). I’ve led you down a pathway of logic that AAFC understood and acted upon. It is applicable to every chronic disease. It has resulted in a unique research facility in Winnipeg: The Canadian Centre for Agri-food Research in Health and Medicine (CCARM).

CCARM melds health and crops in a way that is unique.

Why is CCARM unique? 1.It is found in a medical research setting 2.It goes from bench to bedside in one institution Animal mechanistic research Clinical research Clinical trials Why is CCARM unique? 1.It is found in a medical research setting 2.It goes from bench to bedside in one institution Animal mechanistic research Clinical research Clinical trials

Why is CCARM unique? 3. CCARM has regulatory capacity for foods and trials Trial approval from Health Canada (essential for health claims) Why is CCARM unique? 3. CCARM has regulatory capacity for foods and trials Trial approval from Health Canada (essential for health claims)

Why is CCARM unique? 4. CCARM is a formal agreement (~$32M) amongst AAFC, St Boniface Hospital and the University of Manitoba All of this makes it unique in the world Makes it national Why is CCARM unique? 4. CCARM is a formal agreement (~$32M) amongst AAFC, St Boniface Hospital and the University of Manitoba All of this makes it unique in the world Makes it national

We have a unique positioning of clinical and basic sciences at St Boniface Hospital that allows us to do powerful translational research. How about an example?

Can flaxseed modify cardiovascular disease? A large % of the flax grown in the world is grown in western Canada Contains the essential omega-3 fatty acid - ALA

Does flaxseed provide an anti-atherogenic effect in the LDLr KO mouse? We fed mice a 16 week diet composed of: Regular; 10% flax; cholesterol; cholesterol +10% flax

Conclusions In animals, a flaxseed supplemented diet will strongly inhibit atherosclerosis, improves vascular relaxation, it is an anti- inflammatory and it inhibits arrhythmias.

BENCH TO BEDSIDE We need to apply this bench information to human populations. Does it work in healthy individuals? Does it provide benefits to those with CVD?

What is the best form of flaxseed to provide ALA and how quickly does it rise in the blood? Does flaxseed induce side- effects? (g-i, bleeding times) Will people eat flaxseed daily for up to 3 months? This is all carried out in a healthy young population.

1a

CONCLUSIONS Ground flaxseed and flax oil deliver ALA optimally. We had to study difference in the responses of young and elderly subjects.

Two age groups: years old years old Subjects ingested flaxseed oil (6g ALA) in baked muffins for 4 weeks.

TO BETTER LIVING BENCH TO BEDSIDE TO BETTER LIVING

We have initiated FLAXPAD, a 1 year double blinded, placebo controlled randomized clinical trial that is the first to examine the effects of flaxseed on primary end-points in a patient population with cardiovascular disease.

We will find out if flax decreases heart attacks, stroke and surgical interventions, lowers BP, cholesterol and other fats, decreases arrhythmias, improves exercise performance and alters the genomic response as well.

We will have produced this information while at the same time creating tasty, economical nutritional products that will deliver therapeutic doses of flaxseed (hopefully they will be available to everyone).

IN THE END, WE WILL HAVE TRAVELLED FROM THE LAB BENCH TO THE PATIENT BEDSIDE ONTO BETTER LIVING FOR ALL OF US

THANKS FOR YOUR TIME AND YOUR ATTENTION!!!